Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Behrouz Mansouri Taleghani

Showing results (61-70 of 74) with videos related to

Pageof 8
Sort By:
Bone Marrow Transplantation|June 10, 2018
Peripheral flow-MRD status at the time of autologous stem cell collection predicts outcome in multiple myelomaIvana Moor, Vera U Bacher, Barbara Jeker, et al.
Annals of Hematology|December 25, 2016
BeEAM conditioning with bendamustine-replacing BCNU before autologous transplantation is safe and effective in lymphoma patientsStefanie Gilli, Urban Novak, Behrouz Mansouri Taleghani, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|December 21, 2016
Too Many Blood Donors - Response Bias in the Swiss Health Survey 2012Thomas Volken, Andreas Bänziger, Andreas Buser, et al.
Hamostaseologie|November 13, 2020
Insights from the Hereditary Thrombotic Thrombocytopenic Purpura Registry: Discussion of Key Findings Based on Individual Cases from SwitzerlandJohanna A Kremer Hovinga, Thomas R Braschler, Florian Buchkremer, et al.
Bone Marrow Transplantation|March 21, 2019
High incidence of reversible renal toxicity of dose-intensified bendamustine-based high-dose chemotherapy in lymphoma and myeloma patientsIrene Prediletto, Sarah A Farag, Ulrike Bacher, et al.
Blood Advances|September 12, 2019
Immunoadsorption and autologous transplantation for life-threatening primary antiphospholipid syndromeAnne Angelillo-Scherrer, Behrouz Mansouri Taleghani, Frauke Förger, et al.
Blood Transfusion = Trasfusione Del Sangue|October 11, 2016
Red blood cell use in Switzerland: trends and demographic challengesThomas Volken, Andreas Buser, Damiano Castelli, et al.
Haematologica|March 17, 2004
Splenectomy in relapsing and plasma-refractory acquired thrombotic thrombocytopenic purpuraJohanna A Kremer Hovinga, Jan-Dirk Studt, Franziska Demarmels Biasiutti, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|June 20, 2017
Donor Safety in Haemapheresis: Development of an Internet-Based Registry for Comprehensive Assessment of Adverse Events from Healthy DonorsHans-Gert Heuft, Eike Fischer, Tina Weingand, et al.
Bone Marrow Transplantation|March 28, 2020
A randomized evaluation of vinorelbine versus gemcitabine chemotherapy mobilization of stem cells in myeloma patientsBarbara Jeker, Sarah Farag, Behrouz Mansouri Taleghani, et al.
Pageof 8

Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
Bone Marrow Transplantation|June 10, 2018
Peripheral flow-MRD status at the time of autologous stem cell collection predicts outcome in multiple myelomaIvana Moor, Vera U Bacher, Barbara Jeker, et al.
Annals of Hematology|December 25, 2016
BeEAM conditioning with bendamustine-replacing BCNU before autologous transplantation is safe and effective in lymphoma patientsStefanie Gilli, Urban Novak, Behrouz Mansouri Taleghani, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|December 21, 2016
Too Many Blood Donors - Response Bias in the Swiss Health Survey 2012Thomas Volken, Andreas Bänziger, Andreas Buser, et al.
Hamostaseologie|November 13, 2020
Insights from the Hereditary Thrombotic Thrombocytopenic Purpura Registry: Discussion of Key Findings Based on Individual Cases from SwitzerlandJohanna A Kremer Hovinga, Thomas R Braschler, Florian Buchkremer, et al.
Bone Marrow Transplantation|March 21, 2019
High incidence of reversible renal toxicity of dose-intensified bendamustine-based high-dose chemotherapy in lymphoma and myeloma patientsIrene Prediletto, Sarah A Farag, Ulrike Bacher, et al.
Blood Advances|September 12, 2019
Immunoadsorption and autologous transplantation for life-threatening primary antiphospholipid syndromeAnne Angelillo-Scherrer, Behrouz Mansouri Taleghani, Frauke Förger, et al.
Blood Transfusion = Trasfusione Del Sangue|October 11, 2016
Red blood cell use in Switzerland: trends and demographic challengesThomas Volken, Andreas Buser, Damiano Castelli, et al.
Haematologica|March 17, 2004
Splenectomy in relapsing and plasma-refractory acquired thrombotic thrombocytopenic purpuraJohanna A Kremer Hovinga, Jan-Dirk Studt, Franziska Demarmels Biasiutti, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|June 20, 2017
Donor Safety in Haemapheresis: Development of an Internet-Based Registry for Comprehensive Assessment of Adverse Events from Healthy DonorsHans-Gert Heuft, Eike Fischer, Tina Weingand, et al.
Bone Marrow Transplantation|March 28, 2020
A randomized evaluation of vinorelbine versus gemcitabine chemotherapy mobilization of stem cells in myeloma patientsBarbara Jeker, Sarah Farag, Behrouz Mansouri Taleghani, et al.
Pageof 8